| scholarly article | Q13442814 |
| P50 | author | Reza Dana | Q16206939 |
| Takenori Inomata | Q55536161 | ||
| William Foulsham | Q59296267 | ||
| Yihe Chen | Q88574187 | ||
| P2093 | author name string | Yizhi Liu | |
| Sunil K Chauhan | |||
| Xuhua Tan | |||
| Afsaneh Amouzegar | |||
| P2860 | cites work | Regulation of immune responses by TGF-beta | Q28271433 |
| Thrombospondin-1 is a major activator of TGF-beta1 in vivo | Q28513856 | ||
| Apoptosis of ocular surface cells in experimentally induced dry eye. | Q33185569 | ||
| Thrombospondin-1-N-terminal domain induces a phagocytic state and thrombospondin-1-C-terminal domain induces a tolerizing phenotype in dendritic cells | Q33498950 | ||
| Dendritic cell-derived thrombospondin-1 is critical for the generation of the ocular surface Th17 response to desiccating stress. | Q33732669 | ||
| CD47 engagement inhibits cytokine production and maturation of human dendritic cells | Q73407141 | ||
| The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-beta | Q77388281 | ||
| Hyperosmolarity-induced apoptosis in human corneal epithelial cells is mediated by cytochrome c and MAPK pathways | Q80212121 | ||
| The function of donor versus recipient programmed death-ligand 1 in corneal allograft survival | Q81039605 | ||
| Isolation and characterization of corneal endothelial cells from wild type and thrombospondin-1 deficient mice | Q81348457 | ||
| TGF-beta1 regulation of dendritic cells | Q33804115 | ||
| Epithelial-immune cell interaction in dry eye. | Q33850150 | ||
| Topical interleukin 1 receptor antagonist for treatment of dry eye disease: a randomized clinical trial. | Q34206399 | ||
| Thrombospondins as matricellular modulators of cell function | Q34221349 | ||
| Topical omega-3 and omega-6 fatty acids for treatment of dry eye. | Q34749224 | ||
| Thrombospondin-1 derived from APCs regulates their capacity for allosensitization | Q34953282 | ||
| Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes | Q34973731 | ||
| Conjunctival inflammation in thrombospondin-1 deficient mouse model of Sjögren's syndrome | Q35006085 | ||
| Epidemiology of dry eye syndrome. | Q35076489 | ||
| Thrombospondin-1: multiple paths to inflammation | Q35098885 | ||
| Topical cyclosporine A in the treatment of dry eye: a systematic review and meta-analysis | Q35166231 | ||
| Long-Term Outcome of Treatment with Topical Corticosteroids for Severe Dry Eye Associated with Sjögren's Syndrome | Q35529254 | ||
| Mice with mutations in Fas and Fas ligand demonstrate increased herpetic stromal keratitis following corneal infection with HSV-1 | Q35658941 | ||
| Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease | Q35907009 | ||
| Thrombospondin 1, thrombospondin 2 and the eye. | Q36183490 | ||
| Involvement of pigment epithelium-derived factor, docosahexaenoic acid and neuroprotectin D1 in corneal inflammation and nerve integrity after refractive surgery | Q36201121 | ||
| Thrombospondin 1 Is an Autocrine Negative Regulator of Human Dendritic Cell Activation | Q36371776 | ||
| Effect of desiccating environmental stress versus systemic muscarinic AChR blockade on dry eye immunopathogenesis | Q36758312 | ||
| Dry eye disease: an immune-mediated ocular surface disorder | Q36916372 | ||
| Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression | Q37071969 | ||
| Corneal epithelial proliferation and thickness in a mouse model of dry eye. | Q37269968 | ||
| Sjögren's syndrome-like ocular surface disease in thrombospondin-1 deficient mice | Q37316518 | ||
| Regulation of T-cell chemotaxis by programmed death-ligand 1 (PD-L1) in dry eye-associated corneal inflammation | Q37691860 | ||
| Matricellular protein thrombospondins: influence on ocular angiogenesis, wound healing and immuneregulation | Q38190108 | ||
| TFOS DEWS II pathophysiology report | Q38652987 | ||
| Prevalence of Diagnosed Dry Eye Disease in the United States Among Adults Aged 18 Years and Older | Q38680274 | ||
| Thrombospondin-derived peptide attenuates Sjögren's syndrome-associated ocular surface inflammation in mice | Q39052707 | ||
| Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes. | Q40948258 | ||
| Unique distribution of thrombospondin-1 in human ocular surface epithelium | Q42492608 | ||
| Role of Th17 cells in the immunopathogenesis of dry eye disease | Q42694095 | ||
| TGFbeta mediated transition of corneal fibroblasts from a proinflammatory state to a profibrotic state through modulation of histone acetylation | Q43128396 | ||
| Suppression of thrombospondin 1 and 2 production by herpes simplex virus 1 infection in cultured keratocytes | Q45500284 | ||
| Alterations in corneal stromal dendritic cell phenotype and distribution in inflammation | Q47698171 | ||
| Roles of thrombospondin-1 and -2 in regulating corneal and iris angiogenesis | Q47903593 | ||
| IFN-γ-Expressing Th17 Cells Are Required for Development of Severe Ocular Surface Autoimmunity. | Q48240995 | ||
| Interleukin-7 and -15 maintain pathogenic memory Th17 cells in autoimmunity. | Q48920345 | ||
| Autocrine action of IL-10 suppresses proinflammatory mediators and inflammation in the HSV-1-infected cornea. | Q52542262 | ||
| P433 | issue | 4 | |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 470-477 | |
| P577 | publication date | 2018-07-25 | |
| P1433 | published in | The Ocular Surface | Q15764153 |
| P1476 | title | The immunoregulatory role of corneal epithelium-derived thrombospondin-1 in dry eye disease | |
| P478 | volume | 16 |
| Q90079719 | Dry Eye Disease: Emerging Approaches to Disease Analysis and Therapy | cites work | P2860 |
Search more.